Who Paid My Doc
A 96-Week, Two-Arm, Randomized, Single-Masked, Multi-Center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 MG Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
Research payments
$11,518,412
Through program year 2025, $11,518,412 in research payments was reported against A 96-Week, Two-Arm, Randomized, Single-Masked, Multi-Center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 MG Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy, across 335 payments, paid by Novartis Pharmaceuticals Corporation.
- Paid by
- Novartis Pharmaceuticals Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $78,824 | 12 |
| 2024 | Research | $115,212 | 27 |
| 2023 | Research | $2,219,138 | 113 |
| 2022 | Research | $4,811,075 | 58 |
| 2021 | Research | $4,133,684 | 66 |
| 2020 | Research | $160,479 | 59 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Hani Salehi-Had Huntington Beach, CA Named on 10 payments
- Zachary Segal South Miami, FL Named on 6 payments
- David Brown Bellaire, TX Named on 5 payments
- Shailesh Gupta Pompano Beach, FL Named on 5 payments
- Benjamin Thomas Jacksonville, FL Named on 5 payments
- Cecilia Sanchez Austin, TX Named on 5 payments
- Michael Javaheri Beverly Hills, CA Named on 5 payments
- Shelley Day Austin, TX Named on 4 payments
- Steve Charles Germantown, TN Named on 4 payments
- Liliya Golas Rancho Cordova, CA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.